Eduardo Fernandez-Vicioso, MD
Radiation Oncology · Plantation, FLNPI 1558367722
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,250 of the $6,898 with a category attached, or 61.6%. 27 manufacturers reported payments, led by Novocure Inc. at 40.2% of the total. Reporting peaked in 2021 at $2,804 and has fallen 87.4% since, to $353 in 2025.
Across 91 payments — averaging $75.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$3K
- Dendreon Pharmaceuticals LLC$2K
- Johnson & Johnson$285
- Novartis$261
- Myriad Genetic Laboratories, Inc.$172
- Medtronic$169
- plus $1K from 21 others
Across 2 payments — averaging $1500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$3K
What the payments were for
- Consulting fees$4,25062%
- Food & beverage$2,64838%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 12 | $2,774 |
| Dendreon Pharmaceuticals LLC | 18 | $2,207 |
| Johnson & Johnson | 5 | $285 |
| Novartis | 12 | $261 |
| Myriad Genetic Laboratories, Inc. | 8 | $172 |
| Medtronic | 3 | $169 |
| Advanced Accelerator Applications | 1 | $129 |
| Sumitomo Pharma America, Inc. | 4 | $98 |
| Blue Earth Diagnostics | 3 | $84 |
| Myovant Sciences Inc. | 3 | $72 |
| Boston Scientific | 2 | $71 |
| Eisai Inc. | 1 | $67 |
| Monteris Medical Corporation | 1 | $66 |
| Bayer | 3 | $54 |
| Deciphera Pharmaceuticals Inc. | 2 | $43 |
| Palette Life Sciences, Inc. | 1 | $41 |
| Pfizer | 2 | $40 |
| Reflexion Medical, Inc. | 1 | $39 |
| Teleflex LLC | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Progenics Pharmaceuticals, Inc. | 1 | $30 |
| AbbVie | 1 | $28 |
| Telix Pharmaceuticals | 1 | $27 |
| Tactile Systems Technology Inc | 1 | $26 |
| Lilly USA, LLC | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optune$2,500
- PROVENGE$1,750
- Lutathera$129
- AQUAMANTYS$126
- Erleada$111
How this compares
$6,898 in reported general payments places this provider in the 85th percentile of 465 radiation oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Plantation
- Shravan KandulaOrlando$444K
- Martin KeischMiami Shores$319K
- Marcio FagundesMiami$274K
- Evan ThomasWinter Park$209K
- Rupesh KotechaMiami$208K
- John SylvesterLakewood Ranch$205K
- Ravi ShridharOrlando$192K
- Alan BrownFort Myers$165K
- Akash NandaOrlando$165K
- Michael ChuongMiami$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.